Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 592-597

  Lee, Yong Ho ^a   Lee, Sang Hak ^a   Jung, Eun Suk ^a   Kim, Jung Sun ^a   Shim, Chi Young ^a   Ko, Young Guk ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a   Chung, Namsik ^a   Ha, Jong Won ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Adipokine; Coronary disease; Visceral fat; Waist circumference

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; VISCERA; WAIST CIRCUMFERENCE;

ADULT; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; HUMANS; INTRA-ABDOMINAL FAT; LIPOCALINS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 78649734333     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.012     Document Type: Article

References (28)

1. Després J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
2. Fox C.S., Massaro J.M., Hoffmann U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
3. Mahabadi A.A., Massaro J.M., Rosito G.A., et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009, 30:850-856.
4. Fujimoto W. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999, 22:1808-1812.
5. Hayashi T., Boyko E.J., Leonetti D.L., et al. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 2003, 26:650-655.
6. Rosito G.A., Massaro J.M., Hoffmann U., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008, 117:605-613.
7. Lemieux S., Prud'homme D., Bouchard C., et al. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996, 64:685-693.
8. Megnien J.L., Denarie N., Cocaul M., et al. Predictive value of waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord 1999, 23:90-97.
9. Zamboni M., Turcato E., Armellini F., et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes Relat Metab Disord 1998, 22:655-660.
10. Expert panel on detection E, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
11. Bulcão C., Ferreira S.R., Giuffrida F.M., et al. The new adipose tissue and adipocytokines. Curr Diab Rev 2006, 2:19-28.
12. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062.
13. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
14. New criteria for " obesity disease" in Japan. Circ J 2002, 66:987-992.
15. Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993, 6:137-159.
16. Kim J.A., Choi C.J., Yum K.S. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006, 21:1048-1053.
17. Deurenberg-Yap M., Schmidt G., van Staveren W.A., et al. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes 2000, 24:1011-1017.
18. 2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition 2003, 19:503-509.
19. Wang Y., Lam K.S., Kraegen E.W., et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007, 53:34-41.
20. Hemdahl A.L., Gabrielsen A., Zhu C., et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006, 26:136-142.
21. Choi K.M., Lee J.S., Kim E.J., et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008, 158:203-207.
22. de Lemos J.A., Morrow D.A., Blazing M.A., et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 2007, 50:2117-2124.
23. Fain J.N., Madan A.K. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int J Obes 2005, 29:1299-1307.
24. Bruun J.M., Lihn A.S., Pedersen S.B., et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 2005, 90:2282-2289.
25. Herder C., Baumert J., Thorand B., et al. Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 2006, 26:2147-2152.
26. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004, 44:1812-1818.
27. Fujikawa R., Ito C., Nakashima R., et al. Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels?. Metabolism 2008, 57:506-510.
28. Hyun Y.J., Kim O.Y., Jang Y., et al. Evaluation of metabolic syndrome risk in Korean premenopausal women: not waist circumference but visceral fat. Circ J 2008, 72:1308-1315.